- Tim Cook Should Tell Congress to Kiss His Ass
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
- How the New York Hedge Funds Lost Their Shirts on Tesla
- What You Wear to the Office Still Matters
Stock Futures Retreat on Fed, China Fears
Stock futures are pointing to a down day on Wall Street, as stimulus wind-down and China slowdown worries weigh on the markets.
Thanks to health-conscious millennials, this company is in fine shape.
People will say the stock market is headed for a 1929-style crash if we see yet another positive Tuesday finish.
While I sing a sad song of lackluster fundamentals, Mr. Market sings a happy song of global easing.
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
Investors can clean up with Clean Harbors, have fun with Six Flags and dine out on Whole Foods, Cramer said.
Will big companies really build clouds incompatible with those they can rent?
Wendy's is not completely out of the woods just yet. But the company seems to be heading on the right path.
Insiders at these companies have been scooping up shares of their own stock lately.
Home Depot's strong showing is just a bellwether of a good housing market to come, a Realtors group says.
Dividend-stock ETFs may not be as safe as many shareholders think. A good alternative right now is mega-cap funds.
A study shows 80% of U.S executives still say clothing choices are a big factor in hiring and promotions
'We love the iPhone and the iPad,' isn't a great way to shame a company.
Not ready to give in the minivan yet? Here are 10 vehicles with a sporty, urban and not-at-all parental facade.
Stock futures are pointing to a down day on Wall Street, as stimulus wind-down and China slowdown worries weigh on the markets.
CBOE's Russell Rhoads says there are two pieces of the puzzle that should help lead to the best option to buy or sell depending on your stock price forecast.
In the options market, hefty spreads on the XLF have been noteworthy and seem to be expressing concerns about a possible pullback in months ahead.
If you are unfamiliar with VIX derivatives, this is the week to watch the VIX options and futures move.
Two charts show how investors feel differently about Keryx and Acadia Pharma.
One trader believes Rockwell shares will rise into clinical trial results expected in July.
An updated list of the biotech and drug firms expecting FDA drug approval decisions in 2013.
The New York Post has played pitbull as News Corp. attempts to chip away at Bloomberg's profitable analytics business.
Why taxpayers will only be able to view Tesla as a winning stimulus.
Sony said it will review Loeb's proposal to list part of its entertainment unit.
Jim Cramer looks at why Whole Foods remains well positioned to continue to surge, with Mad Money Research Director Nicole Urken
Investors may have been warming to HP ahead of its second-quarter results, but there are plenty of hurdles in CEO Meg Whitman's path.
HP's first-quarter earnings beat Wall Street expectations, sending the stock soaring in after-hours.
Abercrombie & Fitch issued an apology and pledged to take significant steps following consumer outrage over its CEO's controversial comments.
Stocks fell after FOMC meeting minutes showed several members felt it was time for the Federal Reserve to pull back on stimulus efforts.
'We love the iPhone and the iPad,' isn't a great way to shame a company.
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Delta on Friday will open a long-awaited $1.4 billion terminal at JFK, where it replaced Pan Am to become the largest carrier.
E-Bikes represent an $11 billion global industry and are even replacing cars. MainStreet tries out the newest from Hero Eco/A2B.
When all is said and done, it's all about the actual driving experience.
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
|
|
|
|
|
|
|
|
|
|
|
|